

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.87983642 |
| 2 | desmosome organization (GO:0002934) | 4.07052060 |
| 3 | hemidesmosome assembly (GO:0031581) | 3.99577566 |
| 4 | wound healing, spreading of epidermal cells (GO:0035313) | 3.78788870 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.68713863 |
| 6 | neutrophil activation (GO:0042119) | 3.55811855 |
| 7 | granulocyte activation (GO:0036230) | 3.48975062 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 3.44566239 |
| 9 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.37369597 |
| 10 | cellular response to interferon-alpha (GO:0035457) | 3.35476091 |
| 11 | response to peptidoglycan (GO:0032494) | 3.35195581 |
| 12 | regulation of interleukin-8 secretion (GO:2000482) | 3.31145564 |
| 13 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.26765567 |
| 14 | cell adhesion mediated by integrin (GO:0033627) | 3.26559670 |
| 15 | leukocyte aggregation (GO:0070486) | 3.26420348 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19775269 |
| 17 | wound healing, spreading of cells (GO:0044319) | 3.14869685 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13978971 |
| 19 | negative regulation of cell killing (GO:0031342) | 3.13978971 |
| 20 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.06475197 |
| 21 | barbed-end actin filament capping (GO:0051016) | 3.03059189 |
| 22 | protein localization to endosome (GO:0036010) | 3.00733210 |
| 23 | regulation of monocyte chemotaxis (GO:0090025) | 2.98677087 |
| 24 | membrane raft organization (GO:0031579) | 2.97149165 |
| 25 | interferon-gamma secretion (GO:0072643) | 2.96029360 |
| 26 | endodermal cell differentiation (GO:0035987) | 2.91167395 |
| 27 | skin morphogenesis (GO:0043589) | 2.91084343 |
| 28 | respiratory burst (GO:0045730) | 2.90020945 |
| 29 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.87693253 |
| 30 | detection of other organism (GO:0098543) | 2.87189445 |
| 31 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81902426 |
| 32 | response to interferon-alpha (GO:0035455) | 2.81840878 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 2.81560815 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81560815 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81560815 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81560815 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 2.81560815 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81560815 |
| 39 | hepatocyte apoptotic process (GO:0097284) | 2.81329844 |
| 40 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.80941853 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80423321 |
| 42 | response to muramyl dipeptide (GO:0032495) | 2.77766661 |
| 43 | regulation of chemokine secretion (GO:0090196) | 2.77748866 |
| 44 | regulation of natural killer cell differentiation (GO:0032823) | 2.75398135 |
| 45 | cellular response to zinc ion (GO:0071294) | 2.74637062 |
| 46 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.74190258 |
| 47 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.73133167 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68567056 |
| 49 | response to host (GO:0075136) | 2.68567056 |
| 50 | response to host defenses (GO:0052200) | 2.68567056 |
| 51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68149362 |
| 52 | regulation of hypersensitivity (GO:0002883) | 2.68130807 |
| 53 | sequestering of actin monomers (GO:0042989) | 2.67308799 |
| 54 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.66774579 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 2.64633297 |
| 56 | myeloid cell homeostasis (GO:0002262) | 2.64394493 |
| 57 | detection of bacterium (GO:0016045) | 2.64301217 |
| 58 | pinocytosis (GO:0006907) | 2.62790460 |
| 59 | negative regulation of interleukin-8 production (GO:0032717) | 2.62465974 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.62341103 |
| 61 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62311912 |
| 62 | detection of biotic stimulus (GO:0009595) | 2.61916009 |
| 63 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.61128335 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 2.60438312 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 2.59568320 |
| 66 | positive regulation of actin filament depolymerization (GO:0030836) | 2.57678805 |
| 67 | membrane budding (GO:0006900) | 2.57568583 |
| 68 | amino sugar catabolic process (GO:0046348) | 2.57364497 |
| 69 | pyrimidine nucleoside salvage (GO:0043097) | 2.57290562 |
| 70 | pyrimidine-containing compound salvage (GO:0008655) | 2.57290562 |
| 71 | ribosomal small subunit assembly (GO:0000028) | 2.57237557 |
| 72 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.56971694 |
| 73 | mesodermal cell differentiation (GO:0048333) | 2.56379711 |
| 74 | viral transcription (GO:0019083) | 2.56371687 |
| 75 | Golgi transport vesicle coating (GO:0048200) | 2.56266502 |
| 76 | COPI coating of Golgi vesicle (GO:0048205) | 2.56266502 |
| 77 | sequestering of metal ion (GO:0051238) | 2.53825386 |
| 78 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.53761714 |
| 79 | regulation of superoxide anion generation (GO:0032928) | 2.52687432 |
| 80 | B cell mediated immunity (GO:0019724) | 2.48645656 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 2.47949843 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.47779442 |
| 83 | superoxide anion generation (GO:0042554) | 2.47645387 |
| 84 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47286473 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.46663753 |
| 86 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.46565066 |
| 87 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.45037601 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 2.45005001 |
| 89 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.44283502 |
| 90 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.43484301 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.43244120 |
| 92 | keratinocyte differentiation (GO:0030216) | 2.42488745 |
| 93 | translational termination (GO:0006415) | 2.42240516 |
| 94 | regulation of tolerance induction (GO:0002643) | 2.41241021 |
| 95 | regulation of podosome assembly (GO:0071801) | 2.40692823 |
| 96 | positive regulation of interferon-alpha production (GO:0032727) | 2.40660047 |
| 97 | glycosphingolipid catabolic process (GO:0046479) | 2.40380078 |
| 98 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.39521610 |
| 99 | response to progesterone (GO:0032570) | 2.39229214 |
| 100 | myeloid dendritic cell differentiation (GO:0043011) | 2.39224264 |
| 101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.39197677 |
| 102 | macrophage activation (GO:0042116) | 2.38853271 |
| 103 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.38798734 |
| 104 | natural killer cell mediated immunity (GO:0002228) | 2.38798734 |
| 105 | T-helper 1 type immune response (GO:0042088) | 2.37282571 |
| 106 | positive regulation of interleukin-6 production (GO:0032755) | 2.37213175 |
| 107 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.37054827 |
| 108 | reactive oxygen species biosynthetic process (GO:1903409) | 2.36982424 |
| 109 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.36732296 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.36390361 |
| 111 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.36390361 |
| 112 | positive regulation of type 2 immune response (GO:0002830) | 2.35975721 |
| 113 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.35455147 |
| 114 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.35073575 |
| 115 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.34816626 |
| 116 | negative regulation of interferon-gamma production (GO:0032689) | 2.34749307 |
| 117 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.34422697 |
| 118 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.33665011 |
| 119 | lipoxygenase pathway (GO:0019372) | 2.33498179 |
| 120 | hypotonic response (GO:0006971) | 2.33310988 |
| 121 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.33089181 |
| 122 | detection of external biotic stimulus (GO:0098581) | 2.32877696 |
| 123 | macrophage activation involved in immune response (GO:0002281) | 2.32629876 |
| 124 | germinal center formation (GO:0002467) | 2.32062609 |
| 125 | cellular extravasation (GO:0045123) | 2.31469869 |
| 126 | protein targeting to ER (GO:0045047) | 2.31082631 |
| 127 | regulation of chemokine biosynthetic process (GO:0045073) | 2.30303156 |
| 128 | amyloid precursor protein catabolic process (GO:0042987) | 2.29764892 |
| 129 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.29583240 |
| 130 | regulation of water loss via skin (GO:0033561) | 2.29088573 |
| 131 | regulation of interleukin-6 production (GO:0032675) | 2.28836981 |
| 132 | dendritic cell chemotaxis (GO:0002407) | 2.28053183 |
| 133 | response to fungus (GO:0009620) | 2.27513050 |
| 134 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.26593218 |
| 135 | cotranslational protein targeting to membrane (GO:0006613) | 2.26347898 |
| 136 | positive regulation of chemokine secretion (GO:0090197) | 2.25081511 |
| 137 | regulation of interferon-alpha production (GO:0032647) | 2.24106857 |
| 138 | leukocyte mediated cytotoxicity (GO:0001909) | 2.24036871 |
| 139 | dendritic cell migration (GO:0036336) | 2.23723934 |
| 140 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.23528055 |
| 141 | positive regulation of vesicle fusion (GO:0031340) | 2.22869035 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.22563157 |
| 143 | response to type I interferon (GO:0034340) | 2.22175949 |
| 144 | response to host immune response (GO:0052572) | 2.21948848 |
| 145 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.21948848 |
| 146 | myeloid cell activation involved in immune response (GO:0002275) | 2.21147578 |
| 147 | ribosomal small subunit biogenesis (GO:0042274) | 2.21132068 |
| 148 | cellular response to type I interferon (GO:0071357) | 2.20725015 |
| 149 | type I interferon signaling pathway (GO:0060337) | 2.20725015 |
| 150 | detection of molecule of bacterial origin (GO:0032490) | 2.20342857 |
| 151 | positive regulation of macrophage differentiation (GO:0045651) | 2.19736238 |
| 152 | regulation of metalloenzyme activity (GO:0048552) | 2.19134345 |
| 153 | actin nucleation (GO:0045010) | 2.19036590 |
| 154 | response to interferon-beta (GO:0035456) | 2.18865822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.31583366 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.63453803 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.11915167 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.56977741 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41235658 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.27230164 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26876828 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.91041853 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.90999105 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.82047623 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.80135649 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58923396 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40056060 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29659481 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23546227 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19830819 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19184161 |
| 18 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.15171646 |
| 19 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.15171646 |
| 20 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.11669651 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97840586 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93313558 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91527368 |
| 24 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88193907 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.86809860 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84416987 |
| 27 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.79343656 |
| 28 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.78419962 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.78251904 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77110694 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73726670 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.70829062 |
| 33 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.67576277 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65977370 |
| 35 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.63013334 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61800141 |
| 37 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.60578427 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55879191 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54172845 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.52125527 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.51656842 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47553724 |
| 43 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.47509413 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46777824 |
| 45 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.46162235 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45050204 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43747169 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40895257 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38428944 |
| 50 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38318079 |
| 51 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38172759 |
| 52 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36429767 |
| 53 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35185995 |
| 54 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33638506 |
| 55 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33043910 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.31742463 |
| 57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27426130 |
| 58 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.27422191 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26765764 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26164403 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24956527 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22858792 |
| 63 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.22371392 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21940487 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20667980 |
| 66 | * MAF_26560356_Chip-Seq_TH1_Human | 1.18796803 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18748710 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18648382 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18052665 |
| 70 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17029466 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16874435 |
| 72 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16866542 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16457556 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15685243 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14937966 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14269389 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13306167 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13306167 |
| 79 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12161450 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10339689 |
| 81 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09925779 |
| 82 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09239745 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08893571 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08619926 |
| 85 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07942777 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04600970 |
| 87 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04440369 |
| 88 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03943476 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03579450 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03436947 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02453621 |
| 92 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02032229 |
| 93 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01949495 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01882678 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01726707 |
| 96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00988041 |
| 97 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00149211 |
| 98 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00118063 |
| 99 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00080676 |
| 100 | * MAF_26560356_Chip-Seq_TH2_Human | 0.99605280 |
| 101 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98494012 |
| 102 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98394865 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98011632 |
| 104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97824728 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97289145 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 0.95398418 |
| 107 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94963693 |
| 108 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94063464 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93413110 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93322242 |
| 111 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93173531 |
| 112 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90781120 |
| 113 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90150237 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89367680 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86064512 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85002660 |
| 117 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84441541 |
| 118 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.84066699 |
| 119 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83934478 |
| 120 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.82721087 |
| 121 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82253049 |
| 122 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81161955 |
| 123 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.80829241 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80750209 |
| 125 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.79130389 |
| 126 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.77797217 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77615700 |
| 128 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.77532726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 3.27312827 |
| 2 | MP0003436_decreased_susceptibility_to | 3.06358879 |
| 3 | MP0005275_abnormal_skin_tensile | 3.02300170 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 2.84294755 |
| 5 | MP0003566_abnormal_cell_adhesion | 2.52136776 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.44153693 |
| 7 | MP0009785_altered_susceptibility_to | 2.38119400 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.35282597 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.29826357 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.29078660 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.12652728 |
| 12 | MP0009840_abnormal_foam_cell | 2.01321653 |
| 13 | MP0003724_increased_susceptibility_to | 1.99362490 |
| 14 | MP0002060_abnormal_skin_morphology | 1.99268876 |
| 15 | MP0002796_impaired_skin_barrier | 1.97194273 |
| 16 | MP0003453_abnormal_keratinocyte_physiol | 1.93073835 |
| 17 | MP0000858_altered_metastatic_potential | 1.93030828 |
| 18 | MP0001533_abnormal_skeleton_physiology | 1.91481863 |
| 19 | MP0005023_abnormal_wound_healing | 1.91451336 |
| 20 | MP0000685_abnormal_immune_system | 1.89775028 |
| 21 | MP0002419_abnormal_innate_immunity | 1.88812435 |
| 22 | MP0002254_reproductive_system_inflammat | 1.87753370 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 1.84682861 |
| 24 | MP0003279_aneurysm | 1.81748781 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.80531477 |
| 26 | MP0008260_abnormal_autophagy | 1.79954336 |
| 27 | MP0004947_skin_inflammation | 1.79131759 |
| 28 | MP0003941_abnormal_skin_development | 1.75312698 |
| 29 | MP0005025_abnormal_response_to | 1.75120368 |
| 30 | MP0006054_spinal_hemorrhage | 1.74465321 |
| 31 | MP0003303_peritoneal_inflammation | 1.73693783 |
| 32 | MP0001958_emphysema | 1.70501356 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.65764548 |
| 34 | MP0004272_abnormal_basement_membrane | 1.63407349 |
| 35 | MP0003448_altered_tumor_morphology | 1.61562842 |
| 36 | MP0002006_tumorigenesis | 1.59158890 |
| 37 | MP0001853_heart_inflammation | 1.57882494 |
| 38 | MP0005503_abnormal_tendon_morphology | 1.57863697 |
| 39 | MP0005387_immune_system_phenotype | 1.56319439 |
| 40 | MP0001790_abnormal_immune_system | 1.56319439 |
| 41 | MP0005451_abnormal_body_composition | 1.55292953 |
| 42 | MP0001216_abnormal_epidermal_layer | 1.54909153 |
| 43 | MP0000343_altered_response_to | 1.50823666 |
| 44 | MP0002405_respiratory_system_inflammati | 1.47896028 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.46894358 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.45879881 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.44985409 |
| 48 | MP0005390_skeleton_phenotype | 1.40084762 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.35958670 |
| 50 | MP0005501_abnormal_skin_physiology | 1.35800066 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.34930175 |
| 52 | MP0002132_abnormal_respiratory_system | 1.34803515 |
| 53 | MP0008469_abnormal_protein_level | 1.30583171 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.30352388 |
| 55 | MP0000383_abnormal_hair_follicle | 1.29390737 |
| 56 | MP0005166_decreased_susceptibility_to | 1.29133224 |
| 57 | MP0001346_abnormal_lacrimal_gland | 1.28300342 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.27708945 |
| 59 | MP0002723_abnormal_immune_serum | 1.26249403 |
| 60 | MP0002933_joint_inflammation | 1.26162641 |
| 61 | MP0006082_CNS_inflammation | 1.26116239 |
| 62 | MP0001819_abnormal_immune_cell | 1.25883554 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.24590548 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.23660443 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.22396246 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.18533418 |
| 67 | MP0005165_increased_susceptibility_to | 1.18354381 |
| 68 | MP0001542_abnormal_bone_strength | 1.18078645 |
| 69 | MP0001851_eye_inflammation | 1.17791472 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.17411274 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.17411274 |
| 72 | MP0009278_abnormal_bone_marrow | 1.17018216 |
| 73 | MP0001800_abnormal_humoral_immune | 1.15112224 |
| 74 | MP0009764_decreased_sensitivity_to | 1.15032556 |
| 75 | MP0009384_cardiac_valve_regurgitation | 1.14735219 |
| 76 | MP0001849_ear_inflammation | 1.14188769 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 1.14049931 |
| 78 | MP0005671_abnormal_response_to | 1.13878046 |
| 79 | MP0003091_abnormal_cell_migration | 1.11649422 |
| 80 | MP0005464_abnormal_platelet_physiology | 1.11607269 |
| 81 | MP0003828_pulmonary_edema | 1.10131483 |
| 82 | MP0005164_abnormal_response_to | 1.09023124 |
| 83 | MP0001243_abnormal_dermal_layer | 1.06927362 |
| 84 | MP0010678_abnormal_skin_adnexa | 1.06898513 |
| 85 | MP0002295_abnormal_pulmonary_circulatio | 1.05430472 |
| 86 | MP0003186_abnormal_redox_activity | 1.04690043 |
| 87 | MP0010771_integument_phenotype | 1.02711828 |
| 88 | MP0008004_abnormal_stomach_pH | 1.02165908 |
| 89 | MP0005508_abnormal_skeleton_morphology | 1.00390543 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.98176762 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 0.97866234 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 0.96085686 |
| 93 | MP0003795_abnormal_bone_structure | 0.95449059 |
| 94 | MP0002282_abnormal_trachea_morphology | 0.95401629 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.94591339 |
| 96 | MP0005310_abnormal_salivary_gland | 0.94019145 |
| 97 | MP0000627_abnormal_mammary_gland | 0.93100107 |
| 98 | MP0000377_abnormal_hair_follicle | 0.92341872 |
| 99 | MP0003763_abnormal_thymus_physiology | 0.91634617 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.90668330 |
| 101 | MP0001191_abnormal_skin_condition | 0.90043708 |
| 102 | MP0005257_abnormal_intraocular_pressure | 0.89451954 |
| 103 | MP0009053_abnormal_anal_canal | 0.87574610 |
| 104 | MP0009931_abnormal_skin_appearance | 0.87454298 |
| 105 | MP0000604_amyloidosis | 0.83472532 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.82709817 |
| 107 | MP0001873_stomach_inflammation | 0.82145902 |
| 108 | MP0000733_abnormal_muscle_development | 0.82049703 |
| 109 | MP0004883_abnormal_blood_vessel | 0.81478247 |
| 110 | MP0000678_abnormal_parathyroid_gland | 0.81312509 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.81162566 |
| 112 | MP0004381_abnormal_hair_follicle | 0.80800678 |
| 113 | MP0004510_myositis | 0.79351167 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.78831067 |
| 115 | MP0000716_abnormal_immune_system | 0.78142491 |
| 116 | MP0002429_abnormal_blood_cell | 0.78004850 |
| 117 | MP0002398_abnormal_bone_marrow | 0.77748803 |
| 118 | MP0000490_abnormal_crypts_of | 0.77699222 |
| 119 | MP0005083_abnormal_biliary_tract | 0.77609530 |
| 120 | MP0003075_altered_response_to | 0.77499942 |
| 121 | MP0003045_fibrosis | 0.76999096 |
| 122 | MP0009763_increased_sensitivity_to | 0.75958348 |
| 123 | MP0004858_abnormal_nervous_system | 0.75103561 |
| 124 | MP0003866_abnormal_defecation | 0.74803240 |
| 125 | MP0002009_preneoplasia | 0.74718558 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.73804553 |
| 127 | MP0000579_abnormal_nail_morphology | 0.73214331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.94227316 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.94227316 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.94227316 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.85637054 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.30321368 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.82404676 |
| 7 | Atrophic scars (HP:0001075) | 3.76937999 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.53236582 |
| 9 | Premature rupture of membranes (HP:0001788) | 3.48576316 |
| 10 | Onycholysis (HP:0001806) | 3.43653721 |
| 11 | Interstitial pulmonary disease (HP:0006530) | 3.31418295 |
| 12 | Myositis (HP:0100614) | 3.13971380 |
| 13 | Loss of speech (HP:0002371) | 3.13752391 |
| 14 | Osteolytic defects of the hand bones (HP:0009699) | 3.11759088 |
| 15 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.11759088 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.09918185 |
| 17 | Vertebral compression fractures (HP:0002953) | 3.09333814 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.00834241 |
| 19 | Orchitis (HP:0100796) | 3.00730448 |
| 20 | Fragile nails (HP:0001808) | 2.92782957 |
| 21 | Cervical subluxation (HP:0003308) | 2.92195525 |
| 22 | Peritonitis (HP:0002586) | 2.91811424 |
| 23 | Plantar hyperkeratosis (HP:0007556) | 2.91430493 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.91052448 |
| 25 | Milia (HP:0001056) | 2.89537655 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.86590984 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 2.79583760 |
| 28 | Amyloidosis (HP:0011034) | 2.73292519 |
| 29 | Thick nail (HP:0001805) | 2.72550114 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 2.70933330 |
| 31 | Pustule (HP:0200039) | 2.64047367 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 2.61904993 |
| 33 | Abnormal hemoglobin (HP:0011902) | 2.61214510 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.59162657 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.59162657 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.59162657 |
| 37 | Nasal polyposis (HP:0100582) | 2.54512785 |
| 38 | Nuclear cataract (HP:0100018) | 2.52255672 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.52095041 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.50690318 |
| 41 | Stomatitis (HP:0010280) | 2.49670588 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.48900634 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.48900634 |
| 44 | Gingivitis (HP:0000230) | 2.48185254 |
| 45 | Hepatosplenomegaly (HP:0001433) | 2.47043052 |
| 46 | Obstructive lung disease (HP:0006536) | 2.42119387 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42119387 |
| 48 | Progressive neurologic deterioration (HP:0002344) | 2.37448880 |
| 49 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.33987488 |
| 50 | Periodontitis (HP:0000704) | 2.32369965 |
| 51 | Aortic aneurysm (HP:0004942) | 2.29894059 |
| 52 | Aortic dissection (HP:0002647) | 2.28889067 |
| 53 | Malnutrition (HP:0004395) | 2.28584416 |
| 54 | Increased serum ferritin (HP:0003281) | 2.27463999 |
| 55 | Fragile skin (HP:0001030) | 2.23245458 |
| 56 | Hypotrichosis (HP:0001006) | 2.23127088 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.22397849 |
| 58 | Optic neuritis (HP:0100653) | 2.21668581 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.21668581 |
| 60 | Rough bone trabeculation (HP:0100670) | 2.19514660 |
| 61 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.18679275 |
| 62 | Recurrent skin infections (HP:0001581) | 2.17843043 |
| 63 | Dilatation of the ascending aorta (HP:0005111) | 2.16955103 |
| 64 | Palmoplantar hyperkeratosis (HP:0000972) | 2.16607080 |
| 65 | Skin ulcer (HP:0200042) | 2.13984399 |
| 66 | Disinhibition (HP:0000734) | 2.13488208 |
| 67 | Cellulitis (HP:0100658) | 2.13345239 |
| 68 | Wormian bones (HP:0002645) | 2.10210142 |
| 69 | Pili torti (HP:0003777) | 2.09339455 |
| 70 | Purpura (HP:0000979) | 2.08729789 |
| 71 | Vascular tortuosity (HP:0004948) | 2.05918822 |
| 72 | Short nail (HP:0001799) | 2.05111240 |
| 73 | Woolly hair (HP:0002224) | 2.03760495 |
| 74 | Nail dystrophy (HP:0008404) | 2.03030795 |
| 75 | Urticaria (HP:0001025) | 2.02906882 |
| 76 | Abnormality of nail color (HP:0100643) | 2.02514593 |
| 77 | Anhidrosis (HP:0000970) | 2.01156031 |
| 78 | Abnormality of the pericardium (HP:0001697) | 1.99433120 |
| 79 | Palmar hyperkeratosis (HP:0010765) | 1.97975545 |
| 80 | Alopecia of scalp (HP:0002293) | 1.96861964 |
| 81 | Soft skin (HP:0000977) | 1.96014204 |
| 82 | Increased IgE level (HP:0003212) | 1.93430440 |
| 83 | Oral leukoplakia (HP:0002745) | 1.92773762 |
| 84 | Distal lower limb muscle weakness (HP:0009053) | 1.91914388 |
| 85 | Reticulocytopenia (HP:0001896) | 1.91270800 |
| 86 | Axonal loss (HP:0003447) | 1.91035086 |
| 87 | Spinal rigidity (HP:0003306) | 1.90623081 |
| 88 | Spondylolisthesis (HP:0003302) | 1.89629366 |
| 89 | Ankle contracture (HP:0006466) | 1.88510609 |
| 90 | Myocardial infarction (HP:0001658) | 1.88208710 |
| 91 | Syringomyelia (HP:0003396) | 1.87042406 |
| 92 | Spinal cord lesions (HP:0100561) | 1.87042406 |
| 93 | Beaking of vertebral bodies (HP:0004568) | 1.86723928 |
| 94 | Parakeratosis (HP:0001036) | 1.86652505 |
| 95 | Sparse eyelashes (HP:0000653) | 1.86354852 |
| 96 | Erythema (HP:0010783) | 1.84436417 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 1.84390859 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83609947 |
| 99 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.82963168 |
| 100 | Abnormal trabecular bone morphology (HP:0100671) | 1.82669481 |
| 101 | Prolonged neonatal jaundice (HP:0006579) | 1.82299800 |
| 102 | Vasculitis (HP:0002633) | 1.82013075 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 1.81419992 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.78896173 |
| 105 | Hypertensive crisis (HP:0100735) | 1.78688468 |
| 106 | Thrombocytosis (HP:0001894) | 1.78542426 |
| 107 | Vascular calcification (HP:0004934) | 1.78419636 |
| 108 | Shallow orbits (HP:0000586) | 1.77932605 |
| 109 | Natal tooth (HP:0000695) | 1.77307258 |
| 110 | Anorexia (HP:0002039) | 1.76635635 |
| 111 | Polygenic inheritance (HP:0010982) | 1.76588733 |
| 112 | Osteomyelitis (HP:0002754) | 1.75810561 |
| 113 | Increased cerebral lipofuscin (HP:0011813) | 1.75012145 |
| 114 | Cardiovascular calcification (HP:0011915) | 1.74684791 |
| 115 | Bone pain (HP:0002653) | 1.74429519 |
| 116 | Pathologic fracture (HP:0002756) | 1.74372978 |
| 117 | Episodic fever (HP:0001954) | 1.74275738 |
| 118 | Trismus (HP:0000211) | 1.74215435 |
| 119 | Cerebral aneurysm (HP:0004944) | 1.73610743 |
| 120 | Cheilitis (HP:0100825) | 1.71374712 |
| 121 | Arterial tortuosity (HP:0005116) | 1.71352622 |
| 122 | Congenital, generalized hypertrichosis (HP:0004540) | 1.70688729 |
| 123 | Lip pit (HP:0100267) | 1.70364425 |
| 124 | Micronodular cirrhosis (HP:0001413) | 1.70080075 |
| 125 | Abnormal blistering of the skin (HP:0008066) | 1.69804447 |
| 126 | Increased IgM level (HP:0003496) | 1.69271505 |
| 127 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.68703114 |
| 128 | Pulmonary infiltrates (HP:0002113) | 1.67478010 |
| 129 | Hematochezia (HP:0002573) | 1.67380790 |
| 130 | Follicular hyperkeratosis (HP:0007502) | 1.67180796 |
| 131 | Broad face (HP:0000283) | 1.66274540 |
| 132 | Elbow flexion contracture (HP:0002987) | 1.65768521 |
| 133 | Increased connective tissue (HP:0009025) | 1.64510514 |
| 134 | Neonatal short-limb short stature (HP:0008921) | 1.63891228 |
| 135 | Blue sclerae (HP:0000592) | 1.61188493 |
| 136 | Premature loss of primary teeth (HP:0006323) | 1.57971421 |
| 137 | Biconcave vertebral bodies (HP:0004586) | 1.57195296 |
| 138 | Petechiae (HP:0000967) | 1.57051121 |
| 139 | Abnormality of the nasal mucosa (HP:0000433) | 1.56791712 |
| 140 | Hemoptysis (HP:0002105) | 1.56699932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.13583124 |
| 2 | TESK1 | 3.11029986 |
| 3 | PIM2 | 3.09314639 |
| 4 | ERN1 | 2.68817851 |
| 5 | MST4 | 2.67263614 |
| 6 | MAP3K14 | 2.47624076 |
| 7 | TRPM7 | 2.46152837 |
| 8 | MST1R | 2.36637809 |
| 9 | NME2 | 2.28295290 |
| 10 | MAP3K3 | 2.25822701 |
| 11 | SIK3 | 2.19722050 |
| 12 | RPS6KA4 | 2.19062871 |
| 13 | ERBB3 | 2.16240799 |
| 14 | LRRK2 | 2.15492031 |
| 15 | BLK | 2.03746994 |
| 16 | TBK1 | 1.84361637 |
| 17 | PBK | 1.76428814 |
| 18 | STK10 | 1.76126804 |
| 19 | IRAK4 | 1.70608126 |
| 20 | LIMK1 | 1.62550766 |
| 21 | TRIB3 | 1.55461935 |
| 22 | TYK2 | 1.55194008 |
| 23 | EPHB1 | 1.48470675 |
| 24 | EPHB2 | 1.47201505 |
| 25 | IKBKB | 1.46993286 |
| 26 | MAPKAPK3 | 1.46334995 |
| 27 | NEK9 | 1.44791505 |
| 28 | PIK3CG | 1.37545819 |
| 29 | SIK1 | 1.36525516 |
| 30 | JAK3 | 1.35998518 |
| 31 | TTN | 1.34738483 |
| 32 | IRAK3 | 1.33768744 |
| 33 | SMG1 | 1.32621050 |
| 34 | EPHA3 | 1.29852450 |
| 35 | PAK4 | 1.27034897 |
| 36 | GRK7 | 1.26615367 |
| 37 | TGFBR2 | 1.26466329 |
| 38 | BMX | 1.23201571 |
| 39 | PTK2 | 1.20243823 |
| 40 | RPS6KB2 | 1.16120827 |
| 41 | TESK2 | 1.13603055 |
| 42 | PRPF4B | 1.12467834 |
| 43 | PTK6 | 1.10416662 |
| 44 | ZAP70 | 1.10159537 |
| 45 | IKBKE | 1.09298978 |
| 46 | CSK | 1.07851820 |
| 47 | FER | 1.05059093 |
| 48 | RIPK4 | 1.05002505 |
| 49 | FRK | 1.04435900 |
| 50 | CHUK | 1.04396357 |
| 51 | MAP3K12 | 1.04046765 |
| 52 | MAP2K3 | 1.03342269 |
| 53 | FGR | 1.02356754 |
| 54 | ILK | 1.01857366 |
| 55 | TEC | 1.00320397 |
| 56 | KDR | 1.00250051 |
| 57 | STK24 | 1.00197414 |
| 58 | GRK6 | 0.99883217 |
| 59 | LMTK2 | 0.99470704 |
| 60 | MYLK | 0.99369793 |
| 61 | MAP3K11 | 0.96869203 |
| 62 | MET | 0.96757168 |
| 63 | BTK | 0.95841721 |
| 64 | DDR2 | 0.95177777 |
| 65 | VRK2 | 0.95003280 |
| 66 | PIM1 | 0.90654011 |
| 67 | JAK1 | 0.87992730 |
| 68 | STK3 | 0.87591707 |
| 69 | RIPK1 | 0.86828788 |
| 70 | MAP4K1 | 0.85357854 |
| 71 | ABL2 | 0.84026583 |
| 72 | PRKG2 | 0.83870431 |
| 73 | CDK6 | 0.82695523 |
| 74 | CDC42BPA | 0.80917585 |
| 75 | MAPKAPK2 | 0.80812720 |
| 76 | MOS | 0.79933325 |
| 77 | KIT | 0.75374534 |
| 78 | HCK | 0.74638759 |
| 79 | LATS1 | 0.74301016 |
| 80 | PRKD2 | 0.74197330 |
| 81 | MAP3K2 | 0.69123113 |
| 82 | CSF1R | 0.67477518 |
| 83 | MAP2K2 | 0.67369624 |
| 84 | MAP3K13 | 0.66849187 |
| 85 | BMPR2 | 0.65565373 |
| 86 | FGFR4 | 0.63729619 |
| 87 | STK38 | 0.62387451 |
| 88 | TGFBR1 | 0.62148173 |
| 89 | MATK | 0.61329791 |
| 90 | TNK2 | 0.60980796 |
| 91 | DMPK | 0.60137486 |
| 92 | FGFR3 | 0.60134439 |
| 93 | MAP3K6 | 0.59609260 |
| 94 | ITK | 0.57225740 |
| 95 | DYRK1B | 0.57139369 |
| 96 | TXK | 0.56694809 |
| 97 | MAP2K1 | 0.55681656 |
| 98 | ABL1 | 0.55324882 |
| 99 | PAK2 | 0.55106082 |
| 100 | NUAK1 | 0.54151097 |
| 101 | TAOK2 | 0.53424689 |
| 102 | TAOK1 | 0.53328238 |
| 103 | EIF2AK2 | 0.53020311 |
| 104 | KSR2 | 0.52201149 |
| 105 | PDPK1 | 0.51994006 |
| 106 | PDGFRA | 0.50770112 |
| 107 | PTK2B | 0.50068894 |
| 108 | DAPK1 | 0.48129789 |
| 109 | PDK2 | 0.47557131 |
| 110 | PKN2 | 0.47432378 |
| 111 | PRKCD | 0.46373155 |
| 112 | PAK1 | 0.46077043 |
| 113 | ZAK | 0.44433385 |
| 114 | IRAK2 | 0.43109542 |
| 115 | EIF2AK1 | 0.42474169 |
| 116 | JAK2 | 0.42414082 |
| 117 | MAP3K8 | 0.41724676 |
| 118 | LATS2 | 0.41194356 |
| 119 | LYN | 0.40850461 |
| 120 | LCK | 0.39115033 |
| 121 | MAP3K1 | 0.38413132 |
| 122 | EGFR | 0.38184102 |
| 123 | STK16 | 0.37098797 |
| 124 | MAP3K5 | 0.37065041 |
| 125 | HIPK2 | 0.35836615 |
| 126 | ROCK1 | 0.35255826 |
| 127 | SYK | 0.34936515 |
| 128 | NLK | 0.34531017 |
| 129 | FES | 0.34192655 |
| 130 | ARAF | 0.34092158 |
| 131 | YES1 | 0.33484151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66029021 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.24377434 |
| 3 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.23874910 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.11826648 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.03305339 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 1.92175731 |
| 7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.86062949 |
| 8 | Shigellosis_Homo sapiens_hsa05131 | 1.85870880 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 1.83499417 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81981341 |
| 11 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.79097300 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77884970 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76797211 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.74584413 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73293183 |
| 16 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.73055707 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71469938 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70243683 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65869159 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64578201 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64262594 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.62576651 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.58925059 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.57522557 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.55649071 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54708498 |
| 27 | Amoebiasis_Homo sapiens_hsa05146 | 1.52963304 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.52583165 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.50908172 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.49358720 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47244860 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.45527417 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.42383656 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.41556949 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.41376810 |
| 36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.41339169 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38502752 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.37595818 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 1.37352844 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.32279275 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31745383 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28485952 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27210121 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.22464602 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20421577 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20160994 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20024678 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.16887545 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13994962 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09868455 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06551919 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05794992 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 1.03275442 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01785869 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01523524 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 1.00986683 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.98148684 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94436876 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93963497 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93295718 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92027243 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91364600 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89847797 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88873456 |
| 65 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87817613 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85399839 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.84029223 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83807922 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.81024715 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79044240 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78233924 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77990101 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76461487 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75237096 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75116114 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74894722 |
| 77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72833220 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68932497 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68400530 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68249290 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67727156 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.66114614 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65775055 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65465614 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.63991493 |
| 86 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63702537 |
| 87 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63650960 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63498213 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63217394 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62620464 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61052342 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60332698 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57584978 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56780720 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55968264 |
| 96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55828651 |
| 97 | Melanoma_Homo sapiens_hsa05218 | 0.54690924 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54274222 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53888494 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53519428 |
| 101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52334521 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52155534 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.51800990 |
| 104 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50943415 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.50784500 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50593965 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.49947944 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49707051 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49441628 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49222358 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47806939 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.45744560 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45034862 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44388703 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44280732 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43073819 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37343818 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37057040 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33826610 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32416654 |

